Robert A. Ortenzio - 25 Nov 2024 Form 4 Insider Report for Concentra Group Holdings Parent, Inc. (CON)

Role
Director
Signature
/s/ Timothy Ryan, Attorney-in-Fact
Issuer symbol
CON
Transactions as of
25 Nov 2024
Net transactions value
$0
Form type
4
Filing time
25 Nov 2024, 17:19:51 UTC
Previous filing
05 Aug 2024
Next filing
29 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CON Common Stock Other $0 +5,513,054 $0.000000 5,513,054 25 Nov 2024 Direct F1
transaction CON Common Stock Other $0 +1,032,115 $0.000000 1,032,115 25 Nov 2024 By the Robert A. Ortenzio Descendants Trust F1, F2
transaction CON Common Stock Other $0 +3,070,367 $0.000000 3,070,367 25 Nov 2024 By the Rocco A. Ortenzio Separate Exempt Descendants Trust F1, F2
transaction CON Common Stock Other $0 +226,286 $0.000000 226,286 25 Nov 2024 By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio F1, F2
transaction CON Common Stock Other $0 +226,286 $0.000000 226,286 25 Nov 2024 By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio F1, F2
transaction CON Common Stock Other $0 +226,286 $0.000000 226,286 25 Nov 2024 By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.
F2 The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.